Clinical Trial Update: A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405 [Phase 1]

View source ↗

Summary

Phase 1 study to assess mass balance recovery, metabolite profile, and metabolite identification of [14C]-SK-1405. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Drugs mentioned

• SK-1405

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Pruritus | Phase 1 | Status: COMPLETED